Clariane Revenue as at 30 September 2026

• Revenue at end September 2026 of €4,051m, up +4.7% on an organic basis compared with the same period in 2025
• All activities and regions contributed to revenue growth, supported by favourable volume, price and case mix effects. The average occupancy rate in medicalized nursing homes reached 92.2% for the first nine months of 2026, compared with 90.8% over the same period in 2025, with a notably strong perfor-mance in France in the third quarter
• Success of the €2.3bn debt refinancing programme, with 92% of the Group’s financial debt at fixed rates or hedged. Confirmation by Moody’s of the B2 rating, with a stable outlook
• Integration of the training division of Fondation Œuvre Croix Saint-Simon (7 healthcare and social care training institutes in the Île-de-France region) to strengthen Clariane University’s diploma-granting training offering for nurses and care assistants in France
• Confirmation of all financial and non-financial objectives for the 2023-2026 and 2025-2028 periods 
   

With organic growth of +4.7%, the first nine months of 2026 confirm the strong momentum established in the second half of 2025 across all our business segments and geographies.
In our Long-Term Care activities, the occupancy rate of our nursing homes continued to rise, reaching 92.2% over the first nine months of 2026, an increase of 140 basis points compared with the same period in 2025. I would particularly like to highlight the very strong momentum recorded in France in the third quarter, with an occupancy rate in our medicalized nursing homes of 91.1%, compared with 89.5% over the same period in 2025. Our Specialty Care activities have also returned to positive pricing and volume mo-mentum since Q3 2025, supported by the development of outpatient activities and the measures intro-duced to adapt to the SMR reform in France.
From a financial perspective, we completed our refinancing programme in September, enabling us to simplify our financial structure and extend our debt maturities. With 92% of our debt at fixed rates or hedged, the Group remains largely protected against the recent rise in interest rates and benefits from a strong liquidity position.
I would also like to pay tribute to the remarkable work of our teams over the summer. The thorough preparation of our networks for heatwave and wildfire risks, together with the effective mobilisation of our teams, proved successful. I would like to warmly thank all our teams across our facilities for their commitment, responsiveness and professionalism in caring for the people we support.
Finally, in line with our “Succeed Together” corporate project, we continue to expand our training capabil-ities in the professions that are essential to our activities, through Clariane University, which supports nearly 8,000 employees undertaking diploma-granting training programmes each year. We are taking another step forward in France by integrating the seven healthcare and social care training institutes of Fondation Œuvre Croix Saint-Simon, which train nearly 800 young professionals each year.
On the strength of these results, we confidently confirm all our operational and financial objectives.

Disclaimer
This document contains forward-looking statements that involve risks and uncertainties, including information included or incorporated by reference, concerning the Group's future growth and profitability, which may cause actual results to differ materially from those indicated in the forward-looking statements. These risks and uncertainties are related to factors that the Company cannot control or accurately estimate, such as future market conditions. The forward-looking information contained in this document constitutes expectations about future events and should be considered as such. Actual events or results may differ from those described in this document due to a number of risks and uncertainties described in Chapter 2 of the 2025 Universal Registra-tion Document filed with the AMF on 27 February 2026 under registration number D.26-0054, available on the Company's website (www.clariane.com) and the AMF website (https://www.amf-france.org/fr). All forward-looking statements included in this document are valid only as of the date of this press release. Clariane S.E. makes no commitment and assumes no responsibility to update the information contained in this document beyond what is required by applicable regulations.
Readers should not place undue reliance on these forward-looking statements. Neither Clariane nor any of its directors, officers, employees, agents, affiliates or advisers accepts any responsibility for the reasonableness of the assumptions or opinions expressed or the likelihood of the projections, prospects or returns being realised. Any liability for such information is expressly excluded. Nothing in this document is, or should be considered, a promise or statement for the future. Furthermore, no statement contained in this document is intended to be, or can be interpreted as, a forecast of results. Clariane's past perfor-mance cannot be considered a guide to future performance.
The main alternative performance indicators (APIs), such as "EBITDA", "EBIT", "net debt" and "financial leverage", are defined in the Universal Registration Document available on the company's website.